OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2.

Schallhorn, Julie M; McGee, Selina; Nau, Jeffrey; Macsai, Marian; Gibson, Andrea; Blemker, Gretchen; Hendrix, Laura H; Massaro-Giordano, Mina

Schallhorn, Julie M; McGee, Selina; Nau, Jeffrey; Macsai, Marian; Gibson, Andrea; Blemker, Gretchen; Hendrix, Laura H; Massaro-Giordano, Mina.

Afiliação

Schallhorn JM; Department of Ophthalmology and Francis I, Proctor Foundation, University of California, San Francisco, CA, USA.
McGee S; BeSpoke Vision, Edmond, OK, USA.
Nau J; Oyster Point Pharma, Princeton, NJ, USA.
Macsai M; Oyster Point Pharma, Princeton, NJ, USA.
Gibson A; Oyster Point Pharma, Princeton, NJ, USA.
Blemker G; Oyster Point Pharma, Princeton, NJ, USA.
Hendrix LH; Oyster Point Pharma, Princeton, NJ, USA.
Massaro-Giordano M; Scheie Eye Institute, Penn Dry Eye and Ocular Surface Center, University of Pennsylvania Health System, Philadelphia, PA, USA.

Clin Ophthalmol ; 17: 725-734, 2023.

Article em En | MEDLINE | ID: mdl-36895950

Palavras-chave

Eye Dryness Score; Schirmer test score; Tyrvaya; autoimmune disease; dry eye disease; nicotinic acetylcholine receptor; varenicline nasal spray

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Clin Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google